Načítá se...
Evolving treatment landscape for early and advanced pancreatic cancer
Pancreatic ductal adenocarcinoma is an infrequent cancer with a high disease related mortality rate, even in the context of early stage disease. Until recently, the rate of death from pancreatic cancer has remained largely similar whereby gemcitabine monotherapy was the mainstay of systemic treatmen...
Uloženo v:
| Vydáno v: | World J Gastrointest Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5534396/ https://ncbi.nlm.nih.gov/pubmed/28808501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v9.i7.281 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|